VILLEJUIF, Frankrijk–(BUSINESS WIRE)– WIN 2017 Symposium vindt van 26 tot 27 juni plaats in Parijs. Het door CME geaccrediteerde WIN 2017 is een uitzonderlijk wetenschappelijk evenement gewijd aan het thema “Expediting Global Innovation in Precision Cancer Medicine’’. Het evenement is bedoeld voor alle professionals uit de kankergeneeskunde.
“Het WIN Symposium van 2016 bracht enkele van de meest vooraanstaande wetenschappers bijeen voor lezingen over uiteenlopende onderwerpen, die waarschijnlijk een directe invloed hebben op de behandeling van veel kankerpatiënten”, zei Bruce E. Johnson, president van ASCO® 2017-2018. Johnson gaf de keynote-lezing van de vorige editie van het symposium. ASCO® heeft het WIN Symposium in de afgelopen acht jaar gesteund.
WIN 2017 Symposium, Expediting Global Innovation in Precision Cancer Medicine
VILLEJUIF, France–(BUSINESS WIRE)– WIN 2017 Symposium will be held in Paris, France from June 26-27, 2017. The CME accredited WIN2017 is an exceptional scientific event dedicated to “ Expediting Global Innovation in Precision Cancer Medicine’’ addressed to all cancer care professionals.
This Smart News Release features multimedia. View the full release here:http://www.businesswire.com/news/home/20170208005051/en/
(Graphic: Business Wire)
“ The 2016 WIN symposium brought together some of most distinguished lecturers from around the world covering a broad array of topics that are likely to have a direct impact on the treatment of most of our patients with cancer.” said Bruce E. Johnson, President of ASCO® 2017-2018, who delivered a keynote lecture in the last edition. ASCO® has endorsed the WIN Symposium for the past eight consecutive years.
John Mendelsohn, Chair of WIN Consortium and Past President of The University of Texas MD Anderson Cancer Center will present in his Welcome Address an overview of WIN disruptive programs aiming to significantly improve lung cancer patients’ outcomes.
José Baselga, Memorial Sloan Kettering Cancer Center will discuss in Keynote Opening Lecture “Genomic-driven Clinical Studies in Breast Cancer”.
The Closing Keynote lecture and remarks will be presented by Leroy Hood from Institute for Systems Biology.
The scientific program brings together the greatest academic and industry experts and will develop the following themes:
There will be open discussion with audience participation on each of these topics. In addition, three forums with open discussion for all attendees will debate on how to deliver better treatments to patients and improving their outcomes and these will be published in a synopsis of the symposium.
The authors of the two best posters will be awarded with a prize of 750 euros and invited to an oral presentation at the Symposium.
The Symposium exhibition area is open to all industry to showcase and share their latest research and interact with attendees. The WIN symposium provides excellent networking opportunities between all professionals in cancer care.
For more information, take a look at www.winsymposium.org
For sponsoring opportunities contact: email@example.com
About WIN: WIN Consortium is a non-profit organization based in Paris, France. We are a worldwide network assembling cancer stakeholders from four continents to develop cutting edge concepts and clinical trials that improve survival for cancer patients. WIN members include 28 outstanding cancer centers plus 9 additional leading pharmaceutical, technology companies and patient advocacy organizations representing stakeholders in precision cancer medicine, www.winconsortium.org
ASCO® and American Society of Clinical Oncology® are registered trademarks of the American Society of Clinical Oncology, Inc. Used with permission. This is not an ASCO® sponsored event.